Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States

Clinical Infectious Diseases(2020)10.1093/cid/ciaa142Source: DataRank Database

Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States is a research paper published in Clinical Infectious Diseases (2020). On theSindex it has a DataRank of 0.464. It has been cited 21 times.

N/A

0.464DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)OA: greenTopics (23)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.464

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (5)

Jianghong Li ORCID,Portia Shea,Robert Hecht ORCID,Frederick L. Altice ORCID,Alexei Zelenev ORCID

Live enrichment

PubMed:32060534 PMC:PMC7935393

National Institutes of Health

Grant: K01 DA037826

National Institutes of Health

Grant: K24 DA017072

National Institute on Drug Abuse

Grant: R21 DA041953

National Institute on Drug Abuse

Grant: R01 DA0315940

National Institute on Drug Abuse

Grant: RR19895

National Institute on Drug Abuse

Grant: RR029676

NCRR NIH HHS

Grant: S10 RR019895

NCRR NIH HHS

Grant: S10 RR029676

NIDA NIH HHS

Grant: R01 DA031594

NCATS NIH HHS

Grant: UL1 TR001863

National Institutes of Health

Grant: 5K01DA037826-04

Modeling HIV & Substance Abuse: Correcting Sampling Bias and Cost Effectiveness

National Institutes of Health

Grant: 1S10RR019895-01

YALE BIOMEDICAL SUPERCOMPUTER: GENETICS

National Institutes of Health

Grant: 1S10RR029676-01

High Performance Computing Instrumentation for Yale University Biomedical HPC Cen

National Institutes of Health

Grant: 1R21DA041953-01

Modeling HCV/HIV transmission and Treatment as Prevention in U.S. Networks of People Who Inject Drugs

National Institutes of Health

Grant: 3R01DA031594-03S1

IDU Peer Recruitment Dynamics and Network Structure in Respondent Driven Sampling

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7935393

publisherhttp://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa142/33165784/ciaa142.pdf

publisherhttp://academic.oup.com/cid/article-pdf/72/5/755/36415702/ciaa142.pdf

https://doi.org/10.1093/cid/ciaa142

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7935393

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansHepacivirusHepatitis CSubstance Abuse, IntravenousPharmaceutical PreparationsAntiviral AgentsUnited StatesConnecticut

Keywords

People Who Inject DrugsHcv TreatmentInjection NetworksSyringe Service ProgramOpioid Agonist TherapiesConnecticutPharmaceutical PreparationsHumansHepacivirusSubstance Abuse, IntravenousAntiviral AgentsHepatitis CUnited States

Sustainable Development Goals

SDG 3: 3. Good health